Candriam SCA’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Buy
138,268
+36,588
+36% +$5.36M 0.11% 177
2026
Q1
$12.5M Buy
+101,680
New +$13.4M 0.07% 246
2025
Q2
Sell
-82,131
Closed -$6.52M 700
2025
Q1
$6.52M Sell
82,131
-51,741
-39% -$5.6M 0.04% 285
2024
Q4
$17.9M Sell
133,872
-4,398
-3% -$626K 0.1% 183
2024
Q3
$18M Sell
138,270
-66,773
-33% -$8.24M 0.1% 195
2024
Q2
$21.4M Buy
205,043
+10,998
+6% +$1.23M 0.13% 158
2024
Q1
$25.9M Buy
194,045
+1,520
+0.8% +$204K 0.17% 135
2023
Q4
$26.1M Buy
192,525
+31,008
+19% +$3.58M 0.18% 123
2023
Q3
$21.6M Sell
161,517
-22,632
-12% -$3.72M 0.15% 134
2023
Q2
$33.6M Sell
184,149
-16,247
-8% -$3.29M 0.24% 102
2023
Q1
$41.7M Sell
200,396
-48,131
-19% -$9.85M 0.29% 82
2022
Q4
$48.9M Sell
248,527
-2,884
-1% -$598K 0.33% 70
2022
Q3
$46.7M Buy
251,411
+18,704
+8% +$3.7M 0.33% 70
2022
Q2
$41.7M Sell
232,707
-2,574
-1% -$657K 0.34% 72
2022
Q1
$80M Sell
235,281
-12,003
-5% -$4.05M 0.54% 40
2021
Q4
$91.5M Buy
247,284
+17,375
+8% +$6.58M 0.58% 40
2021
Q3
$90.7M Buy
229,909
+28,128
+14% +$12.9M 0.62% 36
2021
Q2
$92.9M Sell
201,781
-41,684
-17% -$16.8M 0.64% 32
2021
Q1
$84.2M Sell
243,465
-2
-0% -$816 0.7% 26
2020
Q4
$87.6M Sell
243,467
-62,447
-20% -$19.9M 0.69% 26
2020
Q3
$92M Buy
305,914
+117,237
+62% +$40.4M 0.86% 19
2020
Q2
$68M Sell
188,677
-40,605
-18% -$13.1M 0.72% 21
2020
Q1
$72.3M Buy
229,282
+6
+0% +$1.68K 0.8% 19
2019
Q4
$74M Sell
229,276
-40,105
-15% -$12.2M 0.79% 19
2019
Q3
$79.7M Buy
269,381
+12,914
+5% +$3.81M 1.06% 15
2019
Q2
$91.4M Buy
256,467
+19,606
+8% +$6.19M 1.14% 15
2019
Q1
$71.6M Sell
236,861
-720
-0.3% -$210K 0.92% 20
2018
Q4
$69.3M Buy
237,581
+47,447
+25% +$14.7M 1.07% 15
2018
Q3
$67.9M Buy
190,134
+81,544
+75% +$26.1M 0.9% 17
2018
Q2
$29.5M Buy
108,590
+8,944
+9% +$2.28M 0.47% 42
2018
Q1
$22.9M Buy
99,646
+3,346
+3% +$767K 0.39% 61
2017
Q4
$20.5M Sell
96,300
-17,137
-15% -$3.53M 0.35% 71
2017
Q3
$22M Buy
113,437
+13,215
+13% +$2.46M 0.38% 67
2017
Q2
$16.9M Buy
100,222
+19,894
+25% +$3.44M 0.32% 77
2017
Q1
$13.3M Sell
80,328
-16,968
-17% -$2.67M 0.26% 105
2016
Q4
$12.1M Buy
97,296
+2,294
+2% +$309K 0.28% 101
2016
Q3
$16.8M Buy
95,002
+15,536
+20% +$2.49M 0.4% 62
2016
Q2
$10.9M Sell
79,466
-3,714
-4% -$528K 0.28% 92
2016
Q1
$13M Sell
83,180
-8,594
-9% -$1.31M 0.33% 77
2015
Q4
$17.1M Buy
91,774
+4,489
+5% +$724K 0.46% 51
2015
Q3
$14.9M Sell
87,285
-24,852
-22% -$5.02M 0.37% 70
2015
Q2
$23.8M Buy
112,137
+4,111
+4% +$803K 0.5% 48
2015
Q1
$19.5M Buy
108,026
+8,545
+9% +$1.61M 0.39% 64
2014
Q4
$17.9M Buy
+99,481
New +$17.5M 0.37% 78

Other funds holding ILMN

Candriam SCA's ILMN Position: Q2 2026 in Review

Candriam SCA increased its Illumina (ILMN) stake by 36% in Q2 2026, buying an estimated $5.36M and bringing the position to 138,268 shares worth $24.3M. The position accounts for 0.11% of the portfolio, ranked #177.

Candriam SCA first reported a position in ILMN in Q4 2014 and has held it in 44 quarters since. The position peaked at $92.9M in Q2 2021. 932 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Candriam SCA held 138,268 shares of Illumina worth $24.3M as of Q2 2026.
  • Candriam SCA bought 36,588 Illumina shares in Q2 2026, an estimated $5.36M.
  • Illumina made up 0.11% of Candriam SCA's portfolio in Q2 2026, its #177 holding.
  • Candriam SCA first reported a position in Illumina in Q4 2014 and has held it in 44 quarters since.
  • Candriam SCA's Illumina position peaked at $92.9M in Q2 2021.
  • 932 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.